BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9703846)

  • 1. [Pharmacokinetic analysis of low-dose intra-peritoneal cis-platinum administration].
    Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1433-5. PubMed ID: 9703846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
    Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP].
    Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer].
    Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of postoperative immunochemotherapy with a combination of 5-FU, CDDP and lentinan for stage IVb gastric carcinoma and long-term pharmacokinetic studies on CDDP and 5-FU].
    Mio H; Terabe K
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):337-42. PubMed ID: 9051137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Ando N; Kumai K; Kitajima M
    J Surg Oncol; 1996 Jun; 62(2):135-8. PubMed ID: 8649040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
    Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
    Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of low-dose FP therapy for advanced gastric cancer cases].
    Liu X; Gu X; Li Y; Li J; Wang P
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2081-5. PubMed ID: 10584576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal administration of anti-cancer drug with cisplatinum (CDDP)].
    Hirahata S; Kumai K; Hurukawa T; Shimada A; Shibata S; Aizawa K; Matsui H; Takahara T; Shimizu H; Hukase T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1555-60. PubMed ID: 2389948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of platinum accumulation in gastric cancer after preoperative intra-arterial injection of cisplatin].
    Itoh A; Taniguchi H; Daidoh T; Tsukuda N; Shioaki Y; Seiki K; Yokota T; Yamane T; Yamaguchi T; Sawai K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2722-5. PubMed ID: 2782884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological evaluation of neoadjuvant chemotherapy with low-dose FP therapy for advanced gastric cancer].
    Takano S; Oda K; Koda K; Seike K; Takiguchi N; Miyazaki M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):555-8. PubMed ID: 17431341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
    Chen JT; Hasumi K
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):653-7. PubMed ID: 7717717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer].
    Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ
    Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MTX/CDDP/5-FU double modulation intra-peritoneal chemotherapy for advanced and metastatic gastric cancer--comparison with intra-aortic route and intra-venous route].
    Maruyama M; Ebuchi M; Takashima K; Maruyama S; Hasegawa K; Ohbe M; Koide A; Shinoura Y; Katoh K
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1714-6. PubMed ID: 15553692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.